Pure Global AI
NCT06107452Not yet recruiting

Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability

Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability: A Controlled and Randomized Study
Centre Hospitalier Universitaire de Saint EtienneClinicalTrials.govother
Verified
Study focus
Disease/Condition
Acute Coronary Syndrome
Drug/Device/Intervention
training strategy with adaptation of training strategies to the ANS
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Centre Hospitalier Universitaire de Saint Etienne
Location
Saint-Étienne, France
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Feb 01, 2025
Enrollment
110 participants
Primary outcome

The root mean square of successive differences in heart rate or RMSSD

Summary

Cardiac readaptation aims to mitigate cardiovascular risks and enhance the quality of life
 among coronary patients. Our research laboratory has an international expertise in training
 optimization in top-athletes and a previous study has demonstrated the efficacy of optimizing
 cardiac rehabilitation through the power-force-velocity profile (PFVP). The findings
 exhibited significant improvements in aerobic capacity, muscular strength, and cardiovascular
 parameters among patients who were trained based on their PFVP. Guided training utilizing
 heart rate variability (HRV) is also garnering increasing interest as a means to optimize
 training load and promote recovery

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionAcute ischaemic heart disease, unspecifiedOther acute ischaemic heart diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06107452
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06107452 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Saint Etienne and is currently Not yet recruiting. The study focuses on Acute Coronary Syndrome. Target enrollment is 110 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.